Cargando…
Treating ocular surface disease: new agents in development
This paper reviews recent advances and investigation in the treatment of ocular surface pathology. There is significant investment in this area, paralleling the growing demand for more effective alternatives to current treatments. Clinicians are becoming more aware of surface pathology, yet the abil...
Autores principales: | Fahmy, Ahmad M, Hardten, David R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090300/ https://www.ncbi.nlm.nih.gov/pubmed/21573093 http://dx.doi.org/10.2147/OPTH.S12291 |
Ejemplares similares
-
Ocular surface chemical injury treated by regenerating agent (RGTA, Cacicol20)
por: Ustaoglu, Melih, et al.
Publicado: (2017) -
Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
por: Shen, Wencui, et al.
Publicado: (2019) -
Ocular Surface Development and Gene Expression
por: Swamynathan, Shivalingappa K.
Publicado: (2013) -
Glaucoma and Ocular Surface Disease: More than Meets the Eye
por: Li, Gavin, et al.
Publicado: (2022) -
Human Platelets and Derived Products in Treating Ocular Surface Diseases – A Systematic Review
por: You, Jingjing, et al.
Publicado: (2020)